The women’s health diagnostics market was valued at $ 19,152.60 million in 2020, and is projected to reach $ 36,345.36 million by 2030, registering a CAGR of 6.9% from 2021 to 2030.
Women’s health diagnostics is a branch of medical science, which deals with the study, screening & diagnosis of a disease related to women health such as infertility, pregnancy, and different type of cancers. It will help to improve the women’s health & decrees the risk of disease. Different types of medical devices are available for screening and detection of diseases, including biopsy device, imaging & monitoring system, mammography system, and others, which detect cancer, remove blockages, and capture the images of internal organs help for screening & diagnosis of disease. The various types of treatments are also available for diagnosis includes the breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy & ovulation testing & ovarian cancer testing. The use of tests for screening and detection of various disorders is necessary to prevent complications and improve quality of life. Health tests are vital for improving health and preventing and treating serious diseases.
Increase in prevalence of geriatric population of women’s across the globe suffering from different type of cancer, such as breast cancer, cervical cancer, and other, as well as technological advancements in diagnostic test & devices accelerate the market growth. In addition, rise in geriatric population globally boosts the market growth. High cost of imaging & monitoring system and lack of skilled professional impede the growth of the women’s health diagnostics market. Moreover, due to miniaturization of ultrasound devices, untapped emerging economics in developing nations, such as Brazil, India, and UK, have been undergoing rapid changes in terms of healthcare investments and infrastructure, which create lucrative opportunities for key market players.
The women’s health diagnostics market is segmented on the basis of type, end user, and region. On the basis of type, the market is divided into diagnostic devices, diagnostic tests, and accessories and consumables. The devices segment is further segmented into biopsy devices and imaging and monitoring system. Imaging and monitoring systems segment is further segmented into ultrasound device, mammography systems and other. Ultrasound imaging systems is further sub segmented into OB/GYN ultrasound and breast ultrasound. Mammography systems are further categorized as analog mammography systems, digital mammography systems, and breast tomosynthesis system. The diagnostic tests segment is further categorized as breast cancer testing, cervical cancer testing, prenatal genetic screening and carrier testing, pregnancy and ovulation testing, and ovarian cancer testing. Breast cancer testing is further segmented into hormone receptor test, immunohistochemistry test, and other tests. Cervical cancer testing is bifurcated into PAP smear and HPV test. Prenatal genetic screening & carrier testing include tests for cystic fibrosis and other diseases. The pregnancy & ovulation testing segment is further bifurcated into lab-based pregnancy & ovulation testing, and home-based pregnancy & ovulation testing. Depending on end user, the market is categorized into hospitals and clinics, home care settings, diagnostic & imaging centers, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
This report provides comprehensive competitive analysis and profiles of prominent market players ABBOTT, BD, Cardinal Health, Inc., F.Hoffmann-La Roche Ltd., General Electric Company, Hologic, Inc., Koninklijke Philips N.V., Quest Diagnostics Incorporated, Siemens Medical Solutions USA, Inc., and bioMérieux SA.
Women’s health diagnostics is a branch of medical science, which deals with the study, screening & diagnosis of a disease related to women health such as infertility, pregnancy, and different type of cancers. It will help to improve the women’s health & decrees the risk of disease. Different types of medical devices are available for screening and detection of diseases, including biopsy device, imaging & monitoring system, mammography system, and others, which detect cancer, remove blockages, and capture the images of internal organs help for screening & diagnosis of disease. The various types of treatments are also available for diagnosis includes the breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy & ovulation testing & ovarian cancer testing. The use of tests for screening and detection of various disorders is necessary to prevent complications and improve quality of life. Health tests are vital for improving health and preventing and treating serious diseases.
Increase in prevalence of geriatric population of women’s across the globe suffering from different type of cancer, such as breast cancer, cervical cancer, and other, as well as technological advancements in diagnostic test & devices accelerate the market growth. In addition, rise in geriatric population globally boosts the market growth. High cost of imaging & monitoring system and lack of skilled professional impede the growth of the women’s health diagnostics market. Moreover, due to miniaturization of ultrasound devices, untapped emerging economics in developing nations, such as Brazil, India, and UK, have been undergoing rapid changes in terms of healthcare investments and infrastructure, which create lucrative opportunities for key market players.
The women’s health diagnostics market is segmented on the basis of type, end user, and region. On the basis of type, the market is divided into diagnostic devices, diagnostic tests, and accessories and consumables. The devices segment is further segmented into biopsy devices and imaging and monitoring system. Imaging and monitoring systems segment is further segmented into ultrasound device, mammography systems and other. Ultrasound imaging systems is further sub segmented into OB/GYN ultrasound and breast ultrasound. Mammography systems are further categorized as analog mammography systems, digital mammography systems, and breast tomosynthesis system. The diagnostic tests segment is further categorized as breast cancer testing, cervical cancer testing, prenatal genetic screening and carrier testing, pregnancy and ovulation testing, and ovarian cancer testing. Breast cancer testing is further segmented into hormone receptor test, immunohistochemistry test, and other tests. Cervical cancer testing is bifurcated into PAP smear and HPV test. Prenatal genetic screening & carrier testing include tests for cystic fibrosis and other diseases. The pregnancy & ovulation testing segment is further bifurcated into lab-based pregnancy & ovulation testing, and home-based pregnancy & ovulation testing. Depending on end user, the market is categorized into hospitals and clinics, home care settings, diagnostic & imaging centers, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
This report provides comprehensive competitive analysis and profiles of prominent market players ABBOTT, BD, Cardinal Health, Inc., F.Hoffmann-La Roche Ltd., General Electric Company, Hologic, Inc., Koninklijke Philips N.V., Quest Diagnostics Incorporated, Siemens Medical Solutions USA, Inc., and bioMérieux SA.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the womens health diagnostics industry, market segments, current trends, estimations, and dynamics of the womens health diagnostics market analysis from 2020 to 2030 to identify the prevailing womens health diagnostics market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the womens health diagnostics market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global womens health diagnostics market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Accessories and Consumables
- Diagnostic Tests
- Breast Cancer Testing
- Hormone Receptor Test
- Immunohistochemistry (IHC) Test
- Other Tests
- Cervical Cancer Testing
- PAP Smear (PAP) Test
- HPV Test
- Prenatal Genetic Screening and Carrier Testing
- Cystic Fibrosis
- Other Diseases
- Pregnancy and ovulation testing
- Lab based pregnancy and ovulation testing
- Home based pregnancy and ovulation testing
- Ovarian cancer testing
- Diagnostic Devices
- Biopsy Devices
- Imaging and Monitoring System
- Ultrasound Devices
- OB and GYN Ultrasound
- Breast Ultrasound
- Mammography Systems
- Analog Mammography
- Digital Mammography
- Breast Tomosynthesis
- Others
By End User
- Hospitals and Clinics
- Diagnostic and Imaging Centers
- Homecare
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- ABBOTT LABORATORIES
- BECTON, DICKINSON AND COMPANY
- CARDINAL HEALTH, INC.
- F. HOFFMANN-LA ROCHE LTD.
- GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)
- HOLOGIC, INC.
- KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
- QUEST DIAGNOSTICS INCORPORATED.
- SIEMENS AKTIENGESELLSCHAFT
- bioMérieux SA
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: WOMENS HEALTH DIAGNOSTICS MARKET, BY TYPE
CHAPTER 5: WOMENS HEALTH DIAGNOSTICS MARKET, BY END USER
CHAPTER 6: WOMENS HEALTH DIAGNOSTICS MARKET, BY REGION
CHAPTER 7: COMPANY LANDSCAPE
CHAPTER 8: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Womens Health Diagnostics Market,' the womens health diagnostics market size was valued at $19.2 billion in 2020, and is estimated to reach $36.3 billion by 2030, growing at a CAGR of 6.9% from 2021 to 2030.Women’s health diagnostics system improves the women’s health by screening, diagnosing, and monitoring the disease conditions, such as different types of cancer, infertility, and other diseases. The cervical cancer screening supports infertility, prenatal testing, and pregnancy care to breast and ovarian cancer diagnosis to managing bone health & diagnostics. Increase in need for the diagnostics of women’s health-related diseases is considered to be more susceptible to certain disorders, such as osteoporosis, menstrual disorders, cancer, and autoimmune diseases. The major diseases include, menopause, infertility, polycystic ovarian syndrome, and certain cancers, such as breast cancer and cervical cancer, as well as urological disorders. The medical diagnostics devices and tests help to improve the women’s health and accurate treatment against disease.
The key factor that drives the growth of market is rise in the prevalence of osteoarthritis, ovarian cancer, breast cancer, and cervical cancer. Breast cancer is the most commonly occurring cancer in women and the second most common cancer globally. Moreover, high cost of imaging & monitoring system and lack of skilled professionals are responsible for hampering the womens health diagnostics market growth. Moreover, due to miniaturization of ultrasound devices, untapped emerging economics in developing nations, such as Brazil, India, and UK, have been undergoing rapid changes in terms of healthcare investments and infrastructure, which create lucrative opportunities for key market players anticipated to boost the growth of market.
The womens health diagnostics industry is segmented on the basis of type, end user, and region. On the basis of type, the market is divided into diagnostic devices, diagnostic tests, and accessories and consumables. The devices segment is further segmented into biopsy devices and imaging and monitoring system. Imaging and monitoring systems segment is further segmented into ultrasound device, mammography systems & other. Ultrasound imaging systems is further sub segmented into OB/GYN ultrasound and breast ultrasound. Mammography systems are further categorized as analog mammography systems, digital mammography systems, and breast tomosynthesis system. The diagnostic tests segment is further categorized as breast cancer testing, cervical cancer testing, prenatal genetic screening and carrier testing, pregnancy and ovulation testing, and ovarian cancer testing. Breast cancer testing is further segmented into hormone receptor test, immunohistochemistry test, and other tests. Cervical cancer testing is bifurcated into PAP smear and HPV test. Prenatal genetic screening & carrier testing include tests for cystic fibrosis and other diseases. The pregnancy & ovulation testing segment is further bifurcated into lab-based pregnancy & ovulation testing, and home-based pregnancy & ovulation testing. Depending on end user, the market is categorized into hospitals and clinics, home care settings, diagnostic & imaging centers, and others. Based on region, womens health diagnostics industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By type, the market is divided into diagnostic devices, diagnostic tests, and accessories and consumables. The diagnostic tests segment was the highest contributor to the market in 2020. Increase in prevalence of various health-related disorders among women, such as cancer and infertility, growth in awareness about women’s health-related tests, high demand for point-of-care diagnostic testing, and development of numerous diagnostic & imaging centers drive the women’s health diagnostics market for tests.
By end user, the market is categorized into hospitals and clinics, home care settings, diagnostic & imaging centers, and others. The hospitals and clinics segment was the highest contributor to the market in 2020. The increase in incidence of breast and ovarian cancer has led to a significant rise in the number of hospitalization.
By region, North America constituted the highest womens health diagnostics market share in 2020, owing to numerous technological developments related to diagnosis of women and imaging techniques in this region. Asia-Pacific is projected to grow at the highest CAGR during the womens health diagnostics market forecast, owing to entry of novel tests and kits in the market, and rise in awareness about women’s health diagnostics technology.
KEY FINDINGS OF STUDY
- By type, the diagnostic tests was the highest contributor to the market in 2020.
- By end user, the hospitals & clinics segment dominated the market in 2020 and is expected to continue this trend during the forecast period.
- On the basis of womens health diagnostics market analysis, North America garnered the largest revenue share in 2020; however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- ABBOTT LABORATORIES
- BECTON, DICKINSON AND COMPANY
- CARDINAL HEALTH, INC.
- F. HOFFMANN-LA ROCHE LTD.
- GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)
- HOLOGIC, INC.
- KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
- QUEST DIAGNOSTICS INCORPORATED.
- SIEMENS AKTIENGESELLSCHAFT
- bioMérieux SA
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 210 |
| Published | April 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 19152.6 million |
| Forecasted Market Value ( USD | $ 36345.36 million |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
